Consensus $3.18. Sees FY25 adjusted EBITDA at lower end of $356M-$368M. Sees FY25 capital expenditures 2.5%-3% of revenue. Sees FY25 free cash flow $185M. Sees FY25 organic net sales up 1%-3%. The company said, “In fiscal 2025, the Company is taking specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring and repositioning actions, including the organizational and operational changes in Mexico. As a result of these actions, the Company expects to incur pre-tax charges of approximately $29 million for the full fiscal year.”